Tara Bancroft
Stock Analyst at TD Cowen
(2.43)
# 2,498
Out of 5,157 analysts
11
Total ratings
66.67%
Success rate
9.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintains: Buy | $90 → $100 | $97.05 | +3.04% | 2 | Feb 26, 2026 | |
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $21.28 | +59.77% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $9.87 | +102.63% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $83.22 | -3.87% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $29.27 | +70.82% | 1 | Oct 29, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.63 | +513.50% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $5.30 | - | 1 | Aug 31, 2022 |
Protagonist Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $90 → $100
Current: $97.05
Upside: +3.04%
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $21.28
Upside: +59.77%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $9.87
Upside: +102.63%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $83.22
Upside: -3.87%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $29.27
Upside: +70.82%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.63
Upside: +513.50%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $5.30
Upside: -